Randomized Trial of the Efficacy and Safety of Berotralstat (BCX7353) as an Oral Prophylactic Therapy for Hereditary Angioedema: Results of APeX-2 Through 48 Weeks (Part 2)

H. James Wedner, Emel Aygören-Pürsün, Jonathan Bernstein, Timothy Craig, Richard Gower, Joshua S. Jacobs, Douglas T. Johnston, William R. Lumry, Bruce L. Zuraw, Jessica M. Best, Heather A. Iocca, Sharon C. Murray, Bhavisha Desai, Eniko Nagy, William P. Sheridan, Sorena Kiani-Alikhan

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Fingerprint

Dive into the research topics of 'Randomized Trial of the Efficacy and Safety of Berotralstat (BCX7353) as an Oral Prophylactic Therapy for Hereditary Angioedema: Results of APeX-2 Through 48 Weeks (Part 2)'. Together they form a unique fingerprint.

Medicine & Life Sciences